HRMY fund manager activity
Harmony Biosciences Holdings, Inc · Nasdaq. Reported by 3 tracked fund managers in their 13F filings, Q3 2022 to Q2 2026.
Q4 2025
| Manager | Activity | Shares | Value | % of portfolio | Filed |
|---|---|---|---|---|---|
| Jeremy Grantham - GMO | New | 5,371 | $200,983 | 0.00% | Feb 17, 2026 |
| Joel Greenblatt - Gotham Asset Management | Trimmed | 31,773 | $1,188,946 | 0.00% | Feb 17, 2026 |
Q3 2025
| Manager | Activity | Shares | Value | % of portfolio | Filed |
|---|---|---|---|---|---|
| Joel Greenblatt - Gotham Asset Management | Trimmed | 38,898 | $1,072,029 | 0.00% | Nov 14, 2025 |